INIS
therapy
100%
cancer
85%
pancreas
71%
surgery
42%
patients
42%
volume
42%
hazards
42%
hospitals
28%
diseases
28%
data
14%
radiations
14%
clinical trials
14%
comparative evaluations
14%
management
14%
modeling
14%
mortality
14%
morbidity
14%
chemotherapy
14%
adenocarcinomas
14%
Nursing and Health Professions
Patient
85%
Combination Therapy
71%
Surgery
57%
Pancreas Cancer
57%
Survival
42%
Confidence Interval
28%
Chemoradiotherapy
28%
Pancreatectomy
28%
Malignant Neoplasm
28%
Adjuvant Therapy
28%
Volume
28%
Data Base
14%
Morbidity
14%
Perioperative
14%
Hospital Volume
14%
Hospital
14%
Adjuvant Chemotherapy
14%
Pancreas Adenocarcinoma
14%
Mortality
14%
Time
14%
Medicine and Dentistry
Combination Therapy
71%
Surgery
57%
Pancreas Cancer
57%
Therapeutic Procedure
57%
Survival
42%
Chemoradiotherapy
28%
Malignant Neoplasm
28%
Hazard Ratio
28%
Pancreatectomy
28%
Localized Disease
28%
Morbidity
14%
Adjuvant Chemotherapy
14%
Logistic Regression Analysis
14%
Pancreas Adenocarcinoma
14%
Mortality
14%
Clinical Trial
14%
Radiation
14%